Correlation Between Biotechnology Ultrasector and Profunds Ultrashort

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Profunds Ultrashort at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Profunds Ultrashort into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Profunds Ultrashort Nasdaq 100, you can compare the effects of market volatilities on Biotechnology Ultrasector and Profunds Ultrashort and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Profunds Ultrashort. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Profunds Ultrashort.

Diversification Opportunities for Biotechnology Ultrasector and Profunds Ultrashort

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Biotechnology and Profunds is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Profunds Ultrashort Nasdaq 100 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Profunds Ultrashort and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Profunds Ultrashort. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Profunds Ultrashort has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Profunds Ultrashort go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Profunds Ultrashort

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to under-perform the Profunds Ultrashort. In addition to that, Biotechnology Ultrasector is 1.49 times more volatile than Profunds Ultrashort Nasdaq 100. It trades about -0.15 of its total potential returns per unit of risk. Profunds Ultrashort Nasdaq 100 is currently generating about -0.12 per unit of volatility. If you would invest  2,661  in Profunds Ultrashort Nasdaq 100 on September 14, 2024 and sell it today you would lose (132.00) from holding Profunds Ultrashort Nasdaq 100 or give up 4.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Biotechnology Ultrasector Prof  vs.  Profunds Ultrashort Nasdaq 100

 Performance 
       Timeline  
Biotechnology Ultrasector 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Profunds Ultrashort 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Profunds Ultrashort Nasdaq 100 has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Biotechnology Ultrasector and Profunds Ultrashort Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Ultrasector and Profunds Ultrashort

The main advantage of trading using opposite Biotechnology Ultrasector and Profunds Ultrashort positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Profunds Ultrashort can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profunds Ultrashort will offset losses from the drop in Profunds Ultrashort's long position.
The idea behind Biotechnology Ultrasector Profund and Profunds Ultrashort Nasdaq 100 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities